NCT06378853Completed

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

Name: Clinical Trial NCT06378853
Creator: Jinling Hospital, China
Keywords: Pancreatic Cancer, no intervention, other, clinical trial, China

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients Based on Body Compositions Measured by 3D CT Scan and Hematological Indicators

Jinling Hospital, ChinaClinicalTrials.govother

Verified

Study focus

Disease/Condition: Pancreatic Cancer
Drug/Device/Intervention: no intervention
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Jinling Hospital, China
Location: Nanjing, China

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2019
End date: Feb 28, 2024
Enrollment: 548 participants

Primary outcome

complications,overall survival,risk factors

Summary

By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC) admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct correlation analysis with patient clinical information, such as survival time, hospitalization time, nutritional status, hematological indicators, etc., in order to reveal the prognostic factors for overall survival and postoperative complications of PDAC patients.

ICD-10 classifications

Malignant neoplasm of pancreasMalignant neoplasm: Pancreas, unspecifiedMalignant neoplasm: Head of pancreasMalignant neoplasm: Tail of pancreasMalignant neoplasm: Other parts of pancreas

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06378853
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06378853 through Pure Global AI's free database. This phase not specified trial is sponsored by Jinling Hospital, China and is currently Completed. The study focuses on Pancreatic Cancer. Target enrollment is 548 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.